Creating new chemical tools to study diseases
Synthetic Chemical Biology Core
This study is all about creating new tools that help scientists better understand diseases, and it's designed for researchers in Kansas who want to explore how these diseases work using advanced techniques.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Lawrence NIH-funded |
| Lab location | 1 site (Lawrence, United States) |
| Project ID | NIH-10893524 on NIH RePORTER |
What this research studies
The Synthetic Chemical Biology Core (SCB) focuses on developing novel molecular probes that can help researchers understand disease pathways. By synthesizing small molecules and peptides, the SCB provides essential tools for both in vitro and in vivo studies. This initiative supports junior faculty and other investigators in Kansas, enabling them to explore biological problems using advanced chemical biology techniques. The core facility collaborates with other research centers to enhance the effectiveness of these probes in biological research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals involved in biomedical research or those with conditions that could be studied using the developed molecular probes.
Not a fit: Patients who are not engaged in research or do not have conditions relevant to the molecular probes being developed may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for various diseases through the development of innovative chemical tools.
How similar studies have performed: Other research initiatives have successfully utilized similar approaches in chemical biology, indicating a promising potential for this core's objectives.
Where this research is happening
Lawrence, United States
- University of Kansas Lawrence — Lawrence, United States (Active)
Researchers
- Principal investigator: Tunge, Jon a — University of Kansas Lawrence
- Study coordinator: Tunge, Jon a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.